A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV
Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines
Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.
† Indicates status has not been verified in more than two years